At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Duloxetine 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Brain Morphometries in OA Patients Treated With Duloxetine
In Brief
A Phase 4 clinical trial evaluating Duloxetine and Sugar pill for Osteoarthritis. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This study aims to determine in people with knee Osteoarthritis (OA) if relief of pain after treatment with either duloxetine or placebo is associated with changes in brain anatomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
CollaboratorsEli Lilly and Company
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedMar 2012
Primary CompletionApr 2014
Study CompletionAug 2014
TodayJul 2026
First PostedMar 20, 2012
Enrollment StartMar 1, 2012
Primary CompletionApr 1, 2014
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.3 years ago
Interventions
Duloxetinedrug
Duloxetine capsule 30mg once a day for one week, then 60mg once a day for 15 weeks, then 30mg once a day for one week.
Sugar pilldrug
Matching capsule given once a day for a total of 17 weeks.